Baker Bros. Advisors LP Tyra Biosciences, Inc. Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,607 shares of TYRA stock, worth $107,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,607
Previous 10,607
-0.0%
Holding current value
$107,342
Previous $147,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$108 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$41.9 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$41.3 Million90.83% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$41 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$41 Million10.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $425M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...